Psychiatry Centre Södertälje
Södertälje, Stockholm County, 15240, Sweden
NCT Number: NCT04090983
Using a randomized controlled design, standard treatment of group cognitive-behavioral therapy (CBT) according to the Hesslinger protocol is compared to a newly developed group treatment specifically designed for adult patients with ADHD inattentive presentation (ADHD-I) called CBT for ADHD-I (CADDI). Research setting is psychiatric outpatient clinics. Research hypotheses include: 1. The CADDI protocol is more effective than standard treatment in terms of behavioral activation, procrastination, depressive symptoms, functional impairment, and quality of life, 2. Is equally effective in terms of ADHD symptoms, 3. Is more appreciated and tolerable, and 4. Outcome is mediated by mindful awareness. Effects are followed up at 6 and 12 months post treatment.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Södertälje, Stockholm County, 15240, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive-behavioral therapy in a group format focusing on improving symptoms of ADHD, specifically by using skills in counteracting hyperactivity and impulsiveness, and promoting mindful awareness.
Cognitive-behavioral therapy in a group format focusing on improving inattentive symptoms of ADHD, specifically by using skills in organizing, executing, and completing activity, and promoting mindful awareness.
Time frame: 14 weeks
Total score 0-150; higher scores represent increased activation
Time frame: 14 weeks
Total score 12-60; higher scores represent more procrastination
Karolinska Institutet
Other
Group-Based Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05452954
ADHD, ADHD - Combined Type
Groningen, Netherlands
View Trial DetailsNCT01554046
ADHD Predominantly Hyperactivity Type, ADHD Predominantly Inattentive Type
Ramat Gan, Israel
View Trial DetailsNCT03190902
ADHD Predominantly Inattentive Type, Attention Deficit Disorder with Hyperactivity
View Trial DetailsNCT01685281
ADHD Predominantly Inattentive Type, Attention Deficit Disorder with Hyperactivity
Petah Tikva, Israel
View Trial Details